Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

p53 and Tumor Suppression: It Takes a Network
Anthony M. Boutelle, Laura D. Attardi
Trends in Cell Biology (2021) Vol. 31, Iss. 4, pp. 298-310
Open Access | Times Cited: 225

Showing 26-50 of 225 citing articles:

FN1 shapes the behavior of papillary thyroid carcinoma through alternative splicing of EDB region
Mian Liu, Pei Chen, Bo Wei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Application of a high-throughput swarm-based deep neural network Algorithm reveals SPAG5 downregulation as a potential therapeutic target in adult AML
Chinyere I Ajonu, Robert I. Grundy, Graham Ball, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Open Access
Synthesis and Biological Evaluation of Peripheral HTR2A Antagonists for Colorectal Cancer
Minhee Kim, Jihyeon Yoon, Jun Young Choi, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Small molecules that targeting p53 Y220C protein: mechanisms, structures, and clinical advances in anti-tumor therapy
Jinglei Xu, Jiahao Yuan, W. Wang, et al.
Molecular Diversity (2025)
Closed Access
Identification the Cellular Senescence Associated lncRNA LINC01579 in Gastric Cancer
Jingdong He, Ziyi Fu, Boya Zou, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
B. Zhang, H X Zhang, Yan‐Ru Qin
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Review: performance of jujube and its extracts in cancer: therapeutic, toxicity-reducing and potentiating effects
Boyun Gou, Guoqing Chen, Shicong Huang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Research Advances in Hepatocellular Carcinoma Combined Diagnosis of Multiomics Biomarker
红梅 姜
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 2297-2306
Closed Access
Molecular subtyping of small cell lung cancer
Jie Liang, Xiaojiao Guan, Guangyao Bao, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 450-462
Closed Access | Times Cited: 33
miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression
Da Teng, Shaoyou Xia, Shidong Hu, et al.
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 26
Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
Valentina Rocca, Giovanni Blandino, Lucia D’Antona, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3664-3664
Open Access | Times Cited: 26
A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling
Jianong Zhang, Jiangbo Wei, Rui Sun, et al.
Molecular Cell (2023) Vol. 83, Iss. 15, pp. 2692-2708.e7
Open Access | Times Cited: 16
DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma
Shan Wei, Jing Xing, Jia Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)
Xing Ye, Zhouting Tuo, Kai Chen, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 503-515
Open Access | Times Cited: 4
Synthetic lethality of combined ULK1 defection and p53 restoration induce pyroptosis by directly upregulating GSDME transcription and cleavage activation through ROS/NLRP3 signaling
Wei Chen, Kai‐Bin Yang, Yuanzhe Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Understanding p53 tumour suppressor network
Emanuele Panatta, Carlotta Zampieri, Gerry Melino, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 34
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Mengxiong Wang, Laura D. Attardi
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 205-226
Open Access | Times Cited: 34
Regulation of Ferroptosis Pathway by Ubiquitination
Xinbo Wang, Yanjin Wang, Zan Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 31
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Zhangchuan Xia, Ning Kon, Alyssa P. Gu, et al.
Oncogene (2022) Vol. 41, Iss. 22, pp. 3039-3050
Open Access | Times Cited: 25
Time‐series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations
Alba Jiménez, Dan Lü, Marian Kalocsay, et al.
Molecular Systems Biology (2022) Vol. 18, Iss. 3
Open Access | Times Cited: 24
Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53
Kristine Degn, Ludovica Beltrame, Freja Dahl Hede, et al.
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167663-167663
Open Access | Times Cited: 24
A comprehensive study of p53 protein
Manisha R Patil, Anand Bihari
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 12, pp. 1891-1937
Closed Access | Times Cited: 21
Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma
Xinrui Rao, Biyuan Xing, Zilong Wu, et al.
Cancer Science (2023) Vol. 114, Iss. 5, pp. 1943-1957
Open Access | Times Cited: 12
p53 mutation and deletion contribute to tumor immune evasion
Si‐Yang Liu, Tianyao Liu, Jiaxuan Jiang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 12
SLC35F2–SYVN1–TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53
Ben Che, Yunyan Du, Rongfa Yuan, et al.
Oncogene (2023) Vol. 42, Iss. 44, pp. 3260-3273
Closed Access | Times Cited: 12

Scroll to top